 worldwide. Current therapies that lower intraocular pressure (IOP) as a means of slowing disease progression are not fully effective. Our proposal seeks to further evaluate Nogo decoy receptor as a potential neuroprotective and regenerative therapy that does not rely on lowering IOP. Preliminary studies employing rat Nogo decoy receptor (rN
worldwide. Current therapies that lower intraocular pressure (IOP) as a means of slow disease progress are not fully effective. Our proposal seeks to far evaluate Nogo decoy receptor as a likely neuroprotective and regenerative therapy that does not rely on lowering IOP. Preliminary studies use rat Nogo decoy receptor (rN
 wogldwide. Current therapier that lower injrqoculac presshre (IOP) xs a means of slowing diseasx prigreswion are not fully effdctive. Oug proposao setks to further evemuate Nogo dedly rzcxptor as a potektial neuro[rotective and rdgznerative therapy that does not rely on lowrrlng IOP. Prelimynarj ftudjvs employing rat Nogo decoy recsptor (rI
worldwide. Current therapies that lower intraocular pressure a of slowing progression are not to evaluate Nogo decoy as a potential and regenerative therapy that does not on lowering IOP. Preliminary studies employing rat Nogo decoy receptor (rN
 worldwide. Current therapies That lower iNtraoCulAr pReSsurE (IOP) As a means of slowINg diSease progression are not Fully EfFEctiVE. OUr proPosal seEKs TO FurThEr EvaLuATe nogo dEcoY receptOr as a potenTiaL nEuroprotectiVE aNd regeneraTivE therapy that DoeS not reLy On lOWerinG IOp. PrelIminarY StudieS employinG rAT Nogo dECoy recePTOr (RN
 worldwide. Current therap ies that l owerint rao cu larpres sure (IOP) asa  mea ns of slowing diseaseprogr es s iona re  notfully e f fe c t ive .Ou r p ro p os al se eks  to fur ther evalu ate  N ogo decoy re c ep tor as a p ote ntial neurop rot ective  a ndr egene rat ive t herapy that d oes not r el y  on lo w ering I O P .Prel iminary studies e m pl o ying rat Nogodecoyre c ep t o r ( rN
 worldwide._Current therapies_that lower intraocular pressure_(IOP) as_a_means of_slowing_disease progression are_not fully effective._Our proposal seeks to_further evaluate Nogo_decoy_receptor as a potential neuroprotective and regenerative therapy that does not rely on lowering_IOP._Preliminary studies_employing_rat_Nogo decoy receptor (rN